600812 华北制药
已收盘 07-26 15:00:00
资讯
新帖
简况
北向资金7月24日净买入华北制药33.04万股 连续3日增持
自选股智能写手 · 07-25 09:30
北向资金7月24日净买入华北制药33.04万股 连续3日增持
华北制药07月24日主力资金流出128万元 连续3日减仓
自选股智能写手 · 07-24 15:17
华北制药07月24日主力资金流出128万元 连续3日减仓
华北制药获评AA+主体信用等级
纵览新闻 · 07-24 08:29
华北制药获评AA+主体信用等级
肝素概念盘中跳水,华北制药跌1.54%
自选股智能写手 · 07-23
肝素概念盘中跳水,华北制药跌1.54%
北向资金7月19日净卖出华北制药23.24万股 连续5日减持
自选股智能写手 · 07-22
北向资金7月19日净卖出华北制药23.24万股 连续5日减持
华北制药07月19日主力资金流入102万元 连续3日加仓
自选股智能写手 · 07-19
华北制药07月19日主力资金流入102万元 连续3日加仓
千金藤素概念盘中跳水,华北制药跌2.22%
自选股智能写手 · 07-15
千金藤素概念盘中跳水,华北制药跌2.22%
北向资金7月12日净买入华北制药98.49万股 连续3日增持
自选股智能写手 · 07-15
北向资金7月12日净买入华北制药98.49万股 连续3日增持
华北制药(600812)7月11日主力资金净买入2577.60万元
证券之星 · 07-12
华北制药(600812)7月11日主力资金净买入2577.60万元
华北制药最新公告:2023年年度权益分派10派0.1元 股权登记日7月17日
证券之星 · 07-11
华北制药最新公告:2023年年度权益分派10派0.1元 股权登记日7月17日
华北制药(600812.SH)2023年度每股派0.01元 股权登记日为7月17日
智通财经 · 07-11
华北制药(600812.SH)2023年度每股派0.01元 股权登记日为7月17日
7月11日华北制药涨停分析:眼科,维生素,疫苗概念热股
证券之星 · 07-11
7月11日华北制药涨停分析:眼科,维生素,疫苗概念热股
异动快报:华北制药(600812)7月11日13点4分触及涨停板
证券之星 · 07-11
异动快报:华北制药(600812)7月11日13点4分触及涨停板
单抗概念盘中拉升,华北制药涨5.80%
自选股智能写手 · 07-11
单抗概念盘中拉升,华北制药涨5.80%
华北制药:预计2024年1-6月归属净利润盈利约7000万元
证券之星 · 07-10
华北制药:预计2024年1-6月归属净利润盈利约7000万元
华北制药(600812.SH)发预增,预计半年度净利润7000万元,同比增加164%
智通财经 · 07-10
华北制药(600812.SH)发预增,预计半年度净利润7000万元,同比增加164%
华北制药最新公告:预计上半年净利同比增长164%
证券之星 · 07-10
华北制药最新公告:预计上半年净利同比增长164%
华北制药(600812.SH):上半年净利润同比预增164%左右
格隆汇资讯 · 07-10
华北制药(600812.SH):上半年净利润同比预增164%左右
华北制药:预计2024年半年度净利润7000万元 同比增长约164%
财通社 · 07-10
华北制药:预计2024年半年度净利润7000万元 同比增长约164%
华北制药(600812.SH):下属子公司获得政府补助100.5万元
格隆汇资讯 · 07-09
华北制药(600812.SH):下属子公司获得政府补助100.5万元
暂无数据
公司概况
公司名称:
华北制药股份有限公司
所属行业:
医药制造业
上市日期:
1994-01-14
主营业务:
华北制药股份有限公司的主营业务是医药产品的研发、生产和销售等业务。公司产品涉及化学药、生物药、健康消费品等,治疗领域涵盖抗感染药物、心脑血管药物、肾病及免疫调节类药物、肿瘤治疗药物、维生素及健康消费品等700多个品规。公司是首批国家认定企业技术中心、国家“863计划”成果产业化基地、中国青年科技创新行动示范基地、微生物药物国家工程研究中心、抗体药物研制国家重点实验室、抗生素酶催化与结晶技术国家地方联合工程实验室。
发行价格:
4.00
{"stockData":{"symbol":"600812","market":"SH","secType":"STK","nameCN":"华北制药","latestPrice":4.45,"timestamp":1721977200000,"preClose":4.41,"halted":0,"volume":6384600,"delay":0,"floatShares":1716000000,"shares":1716000000,"eps":0.0103,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"07-26 15:00:00","open":4.42,"high":4.48,"low":4.41,"amount":28358200,"amplitude":0.0159,"askPrice":4.45,"askSize":668,"bidPrice":4.44,"bidSize":525,"shortable":0,"etf":0,"ttmEps":0.0103,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":4.41,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":4.85,"lowLimit":3.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1715730370,"pbRate":1.43,"roa":"--","roe":"0.34%","epsLYR":0.003,"committee":-0.288281,"marketValue":7635000000,"floatMarketCap":7635000000,"peRate":432.038827,"changeRate":0.0091,"turnoverRate":0.0037,"status":0},"requestUrl":"/m/hq/s/600812/tweets","defaultTab":"tweets","newsList":[{"id":"2454862169","title":"北向资金7月24日净买入华北制药33.04万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2454862169","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454862169?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:30","pubTimestamp":1721871018,"startTime":"0","endTime":"0","summary":"7月24日, 北向资金增持华北制药33.04万股,连续3日增持。截止当日收盘,沪股通共持有华北制药828.99万股,占流通股0.48%。沪股通增持金额前五个股分别为中信证券、江淮汽车、海尔智家、长电科技、兆易创新。华北制药近5个交易日下跌2.44%,沪股通累计增持24.73万股;近20个交易日上涨2.57%,沪股通累计增持64.41万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072509320295583bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072509320295583bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","600812","BK0191"],"gpt_icon":0},{"id":"2453402021","title":"华北制药07月24日主力资金流出128万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2453402021","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453402021?lang=zh_cn&edition=full","pubTime":"2024-07-24 15:17","pubTimestamp":1721805478,"startTime":"0","endTime":"0","summary":"07月24日, 华北制药股价跌1.57%,报收4.39元,成交金额4205万元,换手率0.55%,振幅2.69%,量比0.74。华北制药今日主力资金净流出128万元,连续3日净流出,上一交易日主力净流出88万元,今日环比增加45.45%。该股近5个交易日下跌2.23%,主力资金累计净流出327万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2763万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241523209ee547eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241523209ee547eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600812","BK0239","BK0191"],"gpt_icon":0},{"id":"2453138230","title":"华北制药获评AA+主体信用等级","url":"https://stock-news.laohu8.com/highlight/detail?id=2453138230","media":"纵览新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453138230?lang=zh_cn&edition=full","pubTime":"2024-07-24 08:29","pubTimestamp":1721780956,"startTime":"0","endTime":"0","summary":"纵览客户端讯 7月12日,经国内权威评级机构评定,华北制药股份有限公司获评AA+主体信用等级,评级展望为稳定。此次获评AA+主体信用等级评定,意味着华北制药在资本市场的品牌影响力得到进一步肯定,公司的核心竞争力、可持续发展能力、经营管理能力、融资能力等得到了国内金融市场的充分认可。这不仅能够大力提升华北制药的品牌形象和市场竞争力,也将为华北制药进一步拓宽融资渠道、降低融资成本、创新融资业务等提供助力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724083028955469af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724083028955469af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0028","BK0239","600812"],"gpt_icon":0},{"id":"2453720497","title":"肝素概念盘中跳水,华北制药跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453720497","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453720497?lang=zh_cn&edition=full","pubTime":"2024-07-23 10:44","pubTimestamp":1721702673,"startTime":"0","endTime":"0","summary":"07月23日,肝素概念盘中跳水,截至10点44分,肝素概念整体指数下跌1.04%,报660.510点。从个股上来看,该概念的成分股中,华北制药跌1.54%,常山药业、双鹭药业、复星医药跌幅居前。从资金上来看,截止发稿,肝素概念主力净流入为-1806.31万,其中力生制药受到资金热捧,主力净流入48.37万;拉长时间线来看,该板块近20日主力资金净流入-3.52亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723104433941f9669&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723104433941f9669&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812","BK0028","BK0191","BK0239"],"gpt_icon":0},{"id":"2453148788","title":"北向资金7月19日净卖出华北制药23.24万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453148788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453148788?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611819,"startTime":"0","endTime":"0","summary":"7月19日,北向资金减持华北制药23.24万股连续5日减持。截止当日收盘,沪股通共持有华北制药731.86万股,占流通股0.42%。沪股通减持金额前五个股分别为XD长江电、兴业银行、国电南瑞、山西汾酒、澜起科技。华北制药近5个交易日上涨1.11%,沪股通累计减持211.67万股;近20个交易日上涨6.56%,沪股通累计减持80.00万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220931539edd4d46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220931539edd4d46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","600812","BK0191"],"gpt_icon":0},{"id":"2452741049","title":"华北制药07月19日主力资金流入102万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2452741049","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452741049?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:17","pubTimestamp":1721373477,"startTime":"0","endTime":"0","summary":"07月19日, 华北制药股价跌0.87%,报收4.55元,成交金额4845万元,换手率0.62%,振幅2.61%,量比0.64。华北制药今日主力资金净流入102万元,连续3日净流入,上一交易日主力净流入263万元,今日环比减少61.22%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.67%,平均涨幅为0.97%。该股近5个交易日上涨1.34%,主力资金累计净流入827万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入3142万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191521449f6a1526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191521449f6a1526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2451665008","title":"千金藤素概念盘中跳水,华北制药跌2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451665008","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451665008?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:47","pubTimestamp":1721008070,"startTime":"0","endTime":"0","summary":"07月15日,千金藤素概念盘中跳水,截至09点47分,千金藤素概念整体指数下跌1.02%,报744.090点。从个股上来看,该概念的成分股中,华北制药跌2.22%,阿拉丁、皓元医药、优宁维跌幅居前。从资金上来看,截止发稿,千金藤素概念主力净流入为-275.18万,其中理邦仪器受到资金热捧,主力净流入134.99万;拉长时间线来看,该板块近20日主力资金净流入-2.73亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150947509681ca11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150947509681ca11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2451650081","title":"北向资金7月12日净买入华北制药98.49万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650081","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451650081?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:30","pubTimestamp":1721007020,"startTime":"0","endTime":"0","summary":"7月12日, 北向资金增持华北制药98.49万股,连续3日增持。截止当日收盘,沪股通共持有华北制药943.53万股,占流通股0.54%。沪股通增持金额前五个股分别为招商银行、中远海控、澜起科技、中国平安、工商银行。华北制药近5个交易日上涨5.63%,沪股通累计增持106.79万股;近20个交易日上涨2.74%,沪股通累计减持76.01万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150932259f4ba58a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150932259f4ba58a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","BK0028","600812"],"gpt_icon":0},{"id":"2450437833","title":"华北制药(600812)7月11日主力资金净买入2577.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450437833","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450437833?lang=zh_cn&edition=full","pubTime":"2024-07-12 08:11","pubTimestamp":1720743099,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月11日收盘,华北制药报收于4.55元,上涨9.9%,涨停,换手率1.37%,成交量23.43万手,成交额1.04亿元。近5日资金流向一览见下表:华北制药融资融券信息显示,融资方面,当日融资买入375.15万元,融资偿还272.65万元,融资净买入102.5万元。融券方面,融券卖出8.58万股,融券偿还9600.0股,融券余量59.81万股,融券余额272.14万元。华北制药主营业务:从事医药产品的研发、生产和销售等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200012404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0239","600812"],"gpt_icon":0},{"id":"2450833673","title":"华北制药最新公告:2023年年度权益分派10派0.1元 股权登记日7月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2450833673","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450833673?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:11","pubTimestamp":1720689064,"startTime":"0","endTime":"0","summary":"华北制药公布2023年年度权益分派实施公告,此次利润分配以方案实施前的公司总股本1,715,730,370股为基数,每股派发现金红利0.01元(含税),共计派发现金红利17,157,303.70元。股权登记日为2024年7月17日,除权(息)日为2024年7月18日。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100034261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2450133529","title":"华北制药(600812.SH)2023年度每股派0.01元 股权登记日为7月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2450133529","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450133529?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:04","pubTimestamp":1720688669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华北制药(600812.SH)发布公告,公司将实施2023年年度权益分派,每股派发现金红利0.01元(含税),股权登记日为7月17日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600812","BK0191","BK0028","BK0239"],"gpt_icon":0},{"id":"2450738476","title":"7月11日华北制药涨停分析:眼科,维生素,疫苗概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450738476","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450738476?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:31","pubTimestamp":1720683104,"startTime":"0","endTime":"0","summary":"证券之星消息,华北制药7月11日涨停收盘,收盘价4.55元。该股于13点4分涨停,1次打开涨停,截止收盘封单资金为929.25万元,占其流通市值0.12%。7月11日的资金流向数据方面,主力资金净流入2577.6万元,占总成交额24.79%,游资资金净流出1404.42万元,占总成交额13.51%,散户资金净流出1173.18万元,占总成交额11.29%。近5日资金流向一览见下表:该股为眼科,维生素,疫苗概念热股,当日眼科概念上涨3.74%,维生素概念上涨3.5%,疫苗概念上涨3.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100024330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600812","BK0239","BK0028","159646"],"gpt_icon":0},{"id":"2450480262","title":"异动快报:华北制药(600812)7月11日13点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2450480262","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450480262?lang=zh_cn&edition=full","pubTime":"2024-07-11 13:05","pubTimestamp":1720674327,"startTime":"0","endTime":"0","summary":"证券之星7月11日盘中消息,13点4分华北制药触及涨停板。目前价格4.55,上涨9.9%。其所属行业化学制药目前上涨。领涨股为圣达生物。该股为眼科,疫苗,肝素概念热股,当日眼科概念上涨4.2%,疫苗概念上涨3.54%,肝素概念上涨3.33%。7月11日的资金流向数据方面,主力资金净流入430.85万元,占总成交额9.38%,游资资金净流出559.64万元,占总成交额12.18%,散户资金净流入128.61万元,占总成交额2.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100022806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600812","BK0191","BK0239"],"gpt_icon":0},{"id":"2450487256","title":"单抗概念盘中拉升,华北制药涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450487256","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450487256?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:50","pubTimestamp":1720662655,"startTime":"0","endTime":"0","summary":"07月11日,单抗概念盘中拉升,截至09点50分,单抗概念整体指数上涨1.05%,报1631.510点。从个股上来看,该概念的成分股中,华北制药涨5.80%,奥泰生物、沃森生物、舒泰神涨幅居前。从资金上来看,截止发稿,单抗概念概念主力净流入为2437.61万,其中恒瑞医药受到资金热捧,主力净流入1314.92万;拉长时间线来看,该板块近20日主力资金净流入-21.61亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110950559681bbc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110950559681bbc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0028","BK0239","600812"],"gpt_icon":0},{"id":"2450998868","title":"华北制药:预计2024年1-6月归属净利润盈利约7000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450998868","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450998868?lang=zh_cn&edition=full","pubTime":"2024-07-10 20:01","pubTimestamp":1720612860,"startTime":"0","endTime":"0","summary":"证券之星消息,华北制药发布业绩预告,预计2024年1-6月归属净利润盈利约7000万元。公告中解释本次业绩变动的原因为:公司通过调整产品结构,加强采购管理,降低采购成本,推行精益管理,深挖成本费用管控等措施,实现盈利能力提升。华北制药2024年一季报显示,公司主营收入25.58亿元,同比下降3.86%;归母净利润1815.24万元,同比上升234.89%;扣非净利润1158.47万元,同比上升290.35%;负债率69.8%,投资收益771.27万元,财务费用1.15亿元,毛利率30.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000042336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812"],"gpt_icon":0},{"id":"2450589531","title":"华北制药(600812.SH)发预增,预计半年度净利润7000万元,同比增加164%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450589531","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450589531?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:35","pubTimestamp":1720611305,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华北制药(600812.SH)发布公告,公司预计2024年半年度实现归属于母公司所有者的净利润7000万元左右,与上年同期相比,将增加4345万元左右,同比增加164%左右。公司通过调整产品结构,加强采购管理,降低采购成本,推行精益管理,深挖成本费用管控等措施,实现盈利能力提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600812"],"gpt_icon":0},{"id":"2450936868","title":"华北制药最新公告:预计上半年净利同比增长164%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450936868","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450936868?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:20","pubTimestamp":1720610441,"startTime":"0","endTime":"0","summary":"华北制药公告,预计2024年半年度实现归母净利润7000万元左右,同比增长164%。公司通过调整产品结构,加强采购管理,降低采购成本,推行精益管理,深挖成本费用管控等措施,实现盈利能力提升。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000040339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600812","BK0191","BK0028"],"gpt_icon":0},{"id":"2450898160","title":"华北制药(600812.SH):上半年净利润同比预增164%左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2450898160","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450898160?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:07","pubTimestamp":1720609674,"startTime":"0","endTime":"0","summary":"格隆汇7月10日丨华北制药(600812.SH)公布2024年半年度业绩预增公告,经财务部门初步测算,预计2024年半年度实现归属于母公司所有者的净利润7,000万元左右,与上年同期相比,将增加4,345万元左右,同比增加164%左右。预计2024年半年度实现归属于母公司所有者的扣除非经常性损益的净利润5,200万元左右,与上年同期相比,将增加5,094万元左右,同比增加4,810%左右。公司通过调整产品结构,加强采购管理,降低采购成本,推行精益管理,深挖成本费用管控等措施,实现盈利能力提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101908129f2cb0a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101908129f2cb0a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812"],"gpt_icon":0},{"id":"2450789816","title":"华北制药:预计2024年半年度净利润7000万元 同比增长约164%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450789816","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450789816?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:07","pubTimestamp":1720609620,"startTime":"0","endTime":"0","summary":"华北制药公告,预计2024年半年度实现归属于母公司所有者的净利润约7000万元,同比增长约164%;扣除非经常性损益后的净利润约5200万元,同比增长约4810%。业绩增长主要得益于公司调整产品结构、加强采购管理和推行精益管理等措施。具体财务数据以公司正式披露的2024年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710190810959e56e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710190810959e56e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812"],"gpt_icon":0},{"id":"2450041228","title":"华北制药(600812.SH):下属子公司获得政府补助100.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450041228","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450041228?lang=zh_cn&edition=full","pubTime":"2024-07-09 20:38","pubTimestamp":1720528680,"startTime":"0","endTime":"0","summary":"格隆汇7月9日丨华北制药(600812.SH)公布,公司下属子公司自2024年7月1日至本公告披露日,共计收到与收益相关的政府补助为人民币100.5万元,占公司2023年度归属于上市公司股东净利润的比例为20.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092038069f257393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092038069f257393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1994-01-14","address":"河北省石家庄市长安区和平东路388号","stockEarnings":[{"period":"1week","weight":-0.0392},{"period":"1month","weight":0.0624},{"period":"3month","weight":-0.0998},{"period":"6month","weight":-0.1053},{"period":"1year","weight":-0.23},{"period":"ytd","weight":-0.2245}],"companyName":"华北制药股份有限公司","boardCode":"AI0027","perCapita":"19904股","boardName":"医药制造业","registeredCapital":"171573万元","compareEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0654},{"period":"6month","weight":-0.0081},{"period":"1year","weight":-0.1043},{"period":"ytd","weight":-0.0296}],"survey":" 华北制药股份有限公司的主营业务是医药产品的研发、生产和销售等业务。公司产品涉及化学药、生物药、健康消费品等,治疗领域涵盖抗感染药物、心脑血管药物、肾病及免疫调节类药物、肿瘤治疗药物、维生素及健康消费品等700多个品规。公司是首批国家认定企业技术中心、国家“863计划”成果产业化基地、中国青年科技创新行动示范基地、微生物药物国家工程研究中心、抗体药物研制国家重点实验室、抗生素酶催化与结晶技术国家地方联合工程实验室。","serverTime":1721986331483,"listedPrice":4,"stockholders":"86197人(较上一季度减少0.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华北制药,600812,华北制药股票,华北制药股票老虎,华北制药股票老虎国际,华北制药行情,华北制药股票行情,华北制药股价,华北制药股市,华北制药股票价格,华北制药股票交易,华北制药股票购买,华北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}